In a community in Kwale district, Kenya, selective mass chemotherapy with metrifonate caused a marked reduction in the intensity of Schistosoma haematobium infection from 46.5 to 9.4 eggs/hr and a sharp fall in prevalence of gross hematuria from 18.3% to 5. 1%, although overall prevalence was reduced only slightly from 67.4% to 54%. The effect of metrifonate on cure rate and reduction of infection intensity was limited by both age and pretreatment infection intensity. Rate of improvement from gross hematuria was similar in all ages and in all classes of intensity of infection. Two doses of metrifonate reduced the prevalence of gross hematuria as much as 3 doses did, while the effect of a single dose on morbidity remains to be clarified.
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Chemotherapy
is playing an increasing role in the control of schistosomiasis and also acts di rectly as a disease control agent.' Thus, the as 
Study area and population
The study was conducted in Kenya at Mwa chinga village, Kwale district, an area known to be highly endemic for urinary schistosomiasis. 3 The number of residents registered at the 1982 census was 1,338 (617 males and 721 females). About half of the people were under 15 years of age.
Urine examination
Pretreatment urine examination was done in December 1983. Urine was collected 1 hr after the previous urination during mid-day. The in tensity of infection was expressed as the number of eggs excreted per 1 hr assessed by the filtration method of Peters.4 The rationale for this method has been published elsewhere.5 The geometric mean was obtained by using the n + 1 transfor mation for a series of egg outputs including zeros. The appearance of urine was classified as yellow, brown (bloody), or red (very bloody). Bloody urine was used as a morbidity indicator, because it is a simple, specific, and sensitive indicator of infection.6
Selective mass chemotherapy
Treatment was given in February and March 1984 and effectiveness was evaluated 4 months later. Subjects passing eggs at least once in 4 previous examinations (June and December 1982, June and December 1983) and all children 5â€"15years old were treated. Metrifonate was scheduled to be given 3 times at a dose of 7.5 mg/kg body weight at 2-week intervals.7
RESULTS

Post-treatment prevalence and intensity of inftction, and frequency of gross hematuria
Urine specimens of 677 villagers were exam ined. Prevalence and intensity of infection and frequency of hematuria showed similar patterns ofvariance withage,all increasing rapidly tothe 10â€"14year group, followed by a steady decline in adults (Table 1 ).Overallprevalenceof he maturia was 18.3%, with 5% (34/677) having very bloody urine.
Out of 813 subjects qualifying for treatment, 690 took metrifonate: in a single dose (n = 118), 2 doses (n = 159), and 3 doses (n = 413).
Four months later, 726 villagers were exam ined for eggs and urine color. The results are were significantly less than those of adultsin each level of intensity of infection (P < 005. x2 statistic).
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METRIFONATEFOR URINARY SCHISTOSOMIASISIN KENYA subjects with hematuria in this group was very small (Table 3) . Table 4 shows the cure rate among subjects receiving 3 doses of metrifonate. Cure rate was not influenced by sex, but varied with age and intensity ofinfection, being significantly lower in children (<14 years) than in adults (>14 years) (P < 0.001). Those with lower egg counts had a higher cure rate than those with initially higher egg counts (P < 0.001). Table 5 compares the cure rate of children and adults who had the same level of infection in tensity. At higher levels of infection, metrifonate was still less effective in children than adults (P < 0.05, x2 statistic). Table 6 shows the geometric mean of egg count among subjects who completed 3 doses of me trifonate. Sex did not affect reduction in egg count, Table 1 . Mass chemotherapy caused a sharp fall in the intensity of infection, though the overallprevalencewas only slightly reduced. Prevalence of hematuria was reduced to less than one third of the pretreatment level, and red urine was observed in only 0.8% of the specimens.
Cure rate in relation to sex, age, and intensity of infection
Reduction of egg output in relation to sex, age, and intensity of infection
Cure rate, reduction in egg output, and gross he maturia in relation to dosage
Among those treated with metrifonate, 336 individuals underwent both pre-and post-treat ment urine examinations (7 samples were not examined for color due to an oversight). Results are shown in Tables 2 and 3 . The cure rate and percent reduction of mean egg output were sig nificantly lower in the groups with fewer doses (P < 0.01). However, reduction of hematuria was not significantly different between the 2-dose and 3-dose groups (Yates' correction, P> 0.5). It was not possible to assess precisely the efficacy of a single dose on hematuriabecausethenumber of 
TABLES
Comparison of parasito/ogica/ cure rate after 3 doses of metrifonate between children and adults showing the same level of intensity of infection
Comparison of reduction in egg count between children and adults showing the same level of intensity of infection
Number of subjects in parentheses.
After the transformation of egg count by log(x + I), differences between pre-and post-treatment were calculated and compared between adults and children.
* Differences were statistically significant.
but the rate of reduction was higher in adults than in children. When adults and children were compared on the basis of intensity of infection at higher bevels (Table 7) , more drastic reductions again were observed in adults than in children
Reduction of prevalence of gross hematuria in relation to sex, age, and intensity of inftction
A total of 232 urine samples were analyzed, with the results shown in Table 8 . The rate of reduction in frequency of bematuria did not dif fer by sex, age, or intensity of infection.
DISCUSSION
The therapeutic efficacy of metrifonate has been reported by many researchers.2'@â€•2 However, most of the reports have dealt exclusively with children as subjects. This study was designed to determine the therapeutic effect of metrifonate at the community level. A marked reduction in infection intensity and prevalence of gross he maturia was observed. Although our study showed only a modest cure rate, the results con firm that selective mass chemotherapy with me trifonate is an effective control strategy for mor bidity due to urinary schistosomiasis.
Infection in children was less responsive to metrifonate than in adults. Lower cure rate and smaller reduction in egg output ofchibdren could be due to the age of the subjects or to higher intensity of infection. It is recognized that cure rate is greatly affected by pretreatment egg count,7'8' 13and also that age plays an important role in the effectiveness of many drugs. '4 The rate of improvement from gross hema turia was similar in all ages and in all but the lowest class of infection intensity, in which prev alence of hematuria was too low to draw a con clusion. The results suggest that morbidity in an entire community decreases homogeneously af ter treatment while intensity of infection remains The improvement of gross he maturia using the 3-dose regimen is comparable to results obtained using praziquante! in Lake Volta, Ghana. '5 Efficacy of metrifonate has been reported to be dose-dependent. 7 This was confirmed by the cure rate and reduction in intensity of infection in our study. The cure rate by 3 doses in our study is lower than that reported from other en demic areas,89 which might be due to either vari ances in infection intensity or to a difference in schistosome susceptibility to metrifonate, as has been suggested by Wilkins and Moore.â€• A single dose of metrifonate showed compar atively marked reduction in urine egg count. 0. @2 Three out of 6 subjects with hematuria at pre treatment were negative and without red urine at post-treatment examination after a single dose. This indicates a promising effect of single-dose metrifonate on morbidity due to S. haemato bium infection. Two doses of metrifonate re duced prevalence of gross hematuria similarly to 3 doses; therefore a 2-dose regimen is recom mended and expected to increase compliance, as it did in our study by 20%. This study was supported by the Kenya Med ical Research Institute, Ministry of Health, Ken ya, and the Japan International Cooperation Agency, Japan.
